Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study

被引:20
作者
Abdulfatah, Eman [1 ]
Lordello, Leonardo [3 ]
Khurram, Muhammad [2 ]
Van de Vijver, Koen [3 ]
Alosh, Baraa [1 ]
Bandyopadhyay, Sudeshna [1 ]
Oliva, Esther [3 ]
Ali-Fehmi, Rouba [1 ]
机构
[1] Wayne State Univ, Dept Pathol, 540 East Canfield Ave, Detroit, MI 48202 USA
[2] St Johns Providence Hosp, Dept Pathol, Detroit, MI USA
[3] Harvard Univ, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
Carcinosarcoma; MMMT; Rhabdomyoblastic; Survival; MIXED MULLERIAN TUMORS; PROGNOSTIC-FACTORS; UTERINE CARCINOSARCOMA; ADJUVANT RADIOTHERAPY; MESENCHYMAL TUMORS; MESODERMAL TUMORS; STAGE-I; SARCOMA; CARCINOMA; COMPONENTS;
D O I
10.1097/PGP.0000000000000497
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Uterine carcinosarcomas are rare aggressive biphasic neoplasms. Because of its rarity, limited data are available on potential prognostic parameters. While several studies support that carcinomatous components predict outcomes, others do not. In this study, we evaluated the clinical and histopathologic features of 196 uterine carcinosarcomas to identify potential prognostic factors. Patients' ages ranged from 34 to 95 yr (median, 68 yr). Seventy-three (38%) patients experienced tumor recurrence during follow-up. Tumors >= 5 cm, outer half myometrial invasion, lymphovascular invasion, lymph node metastasis, advanced stage (International Federation of Gynecology and Obstetrics stages III-IV), sarcomatous component on recurrence, sarcoma dominance, and positive cytology were significantly associated with shorter disease-free interval (P<0.05). In addition, serous histology and rhabdomyoblastic differentiation was significantly associated with worse 3-yr overall survival. Our data supports that both carcinomatous and sarcomatous components play a role in tumor progression and survival of uterine carcinosarcoma patients, suggesting their equal importance in guiding management decisions.
引用
收藏
页码:205 / 215
页数:11
相关论文
共 43 条
[31]  
Schwartz SM, 1996, CANCER, V77, P717, DOI 10.1002/(SICI)1097-0142(19960215)77:4<717::AID-CNCR18>3.0.CO
[32]  
2-3
[33]   PROGNOSTIC FACTORS FOR MALIGNANT MIXED MULLERIAN TUMORS OF THE UTERUS [J].
SCHWEIZER, W ;
DEMOPOULOS, R ;
BELLER, U ;
DUBIN, N .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1990, 9 (02) :129-136
[34]   CARCINOSARCOMA (MALIGNANT MIXED MESODERMAL TUMOR) OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP PATHOLOGICAL-STUDY OF 203 CASES [J].
SILVERBERG, SG ;
MAJOR, FJ ;
BLESSING, JA ;
FETTER, B ;
ASKIN, FB ;
LIAO, SY ;
MILLER, A .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1990, 9 (01) :1-19
[35]  
SPANOS WJ, 1984, CANCER-AM CANCER SOC, V53, P311, DOI 10.1002/1097-0142(19840115)53:2<311::AID-CNCR2820530222>3.0.CO
[36]  
2-X
[37]   CARCINOSARCOMAS OF THE FEMALE GENITAL-TRACT - A PATHOLOGICAL-STUDY OF 29 METASTATIC TUMORS - FURTHER EVIDENCE FOR THE DOMINANT ROLE OF THE EPITHELIAL COMPONENT AND THE CONVERSION THEORY OF HISTOGENESIS [J].
SREENAN, JJ ;
HART, WR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (06) :666-674
[38]   Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma [J].
Vaidya, Ami P. ;
Horowitz, Neil S. ;
Oliva, Esther ;
Halpern, Elkan F. ;
Duska, Linda R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :684-687
[39]   THE EFFECT OF CHEMOTHERAPY ON THE DIFFERENT COMPONENTS OF ADVANCED CARCINOSARCOMAS (MALIGNANT MIXED MESODERMAL TUMORS) OF THE FEMALE GENITAL-TRACT [J].
VANRIJSWIJK, REN ;
TOGNON, G ;
BURGER, CW ;
BAAK, JP ;
KENEMANS, P ;
VERMORKEN, JB .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (01) :52-60
[40]   UTERINE SARCOMA - ANALYSIS OF PROGNOSTIC VARIABLES IN 71 CASES [J].
WHEELOCK, JB ;
KREBS, HB ;
SCHNEIDER, V ;
GOPLERUD, DR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 151 (08) :1016-1022